These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

964 related items for PubMed ID: 24858378

  • 1. A human cancer xenograft model utilizing normal pancreatic duct epithelial cells conditionally transformed with defined oncogenes.
    Inagawa Y, Yamada K, Yugawa T, Ohno S, Hiraoka N, Esaki M, Shibata T, Aoki K, Saya H, Kiyono T.
    Carcinogenesis; 2014 Aug; 35(8):1840-6. PubMed ID: 24858378
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.
    Vaz AP, Deb S, Rachagani S, Dey P, Muniyan S, Lakshmanan I, Karmakar S, Smith L, Johansson S, Lele S, Ouellette M, Ponnusamy MP, Batra SK.
    Oncotarget; 2016 Jan 19; 7(3):3317-31. PubMed ID: 26689992
    [Abstract] [Full Text] [Related]

  • 3. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
    Qian J, Niu J, Li M, Chiao PJ, Tsao MS.
    Cancer Res; 2005 Jun 15; 65(12):5045-53. PubMed ID: 15958547
    [Abstract] [Full Text] [Related]

  • 4. Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes.
    Sasaki R, Narisawa-Saito M, Yugawa T, Fujita M, Tashiro H, Katabuchi H, Kiyono T.
    Carcinogenesis; 2009 Mar 15; 30(3):423-31. PubMed ID: 19126650
    [Abstract] [Full Text] [Related]

  • 5. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC, Sancho P, Cañamero M, Martinelli P, Madriles F, Michl P, Gress T, de Pascual R, Gandia L, Guerra C, Barbacid M, Wagner M, Vieira CR, Aicher A, Real FX, Sainz B, Heeschen C.
    Gastroenterology; 2014 Nov 15; 147(5):1119-33.e4. PubMed ID: 25127677
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Organoid-based ex vivo reconstitution of Kras-driven pancreatic ductal carcinogenesis.
    Matsuura T, Maru Y, Izumiya M, Hoshi D, Kato S, Ochiai M, Hori M, Yamamoto S, Tatsuno K, Imai T, Aburatani H, Nakajima A, Hippo Y.
    Carcinogenesis; 2020 Jun 17; 41(4):490-501. PubMed ID: 31233118
    [Abstract] [Full Text] [Related]

  • 10. Oncogenic ERBB2 aberrations and KRAS mutations cooperate to promote pancreatic ductal adenocarcinoma progression.
    Li Z, Shao C, Liu X, Lu X, Jia X, Zheng X, Wang S, Zhu L, Li K, Pang Y, Xie F, Lu Y, Wang Y.
    Carcinogenesis; 2020 Mar 13; 41(1):44-55. PubMed ID: 31046123
    [Abstract] [Full Text] [Related]

  • 11. Bmi1 combines with oncogenic KRAS to induce malignant transformation of human pancreatic duct cells in vitro.
    Chen SJ, Chen YT, Zeng LJ, Zhang QB, Lian GD, Li JJ, Yang KG, Huang CM, Li YQ, Chu ZH, Huang KH.
    Tumour Biol; 2016 Aug 13; 37(8):11299-309. PubMed ID: 26951514
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Kras(G12D) induces EGFR-MYC cross signaling in murine primary pancreatic ductal epithelial cells.
    Diersch S, Wirth M, Schneeweis C, Jörs S, Geisler F, Siveke JT, Rad R, Schmid RM, Saur D, Rustgi AK, Reichert M, Schneider G.
    Oncogene; 2016 Jul 21; 35(29):3880-6. PubMed ID: 26592448
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of G1-S cyclins and cyclin-dependent kinases during multistage human pancreatic duct cell carcinogenesis.
    Al-Aynati MM, Radulovich N, Ho J, Tsao MS.
    Clin Cancer Res; 2004 Oct 01; 10(19):6598-605. PubMed ID: 15475449
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. SETDB1 Inhibits p53-Mediated Apoptosis and Is Required for Formation of Pancreatic Ductal Adenocarcinomas in Mice.
    Ogawa S, Fukuda A, Matsumoto Y, Hanyu Y, Sono M, Fukunaga Y, Masuda T, Araki O, Nagao M, Yoshikawa T, Goto N, Hiramatsu Y, Tsuda M, Maruno T, Nakanishi Y, Hussein MS, Tsuruyama T, Takaori K, Uemoto S, Seno H.
    Gastroenterology; 2020 Aug 01; 159(2):682-696.e13. PubMed ID: 32360551
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A genetically engineered mouse model developing rapid progressive pancreatic ductal adenocarcinoma.
    Yamaguchi T, Ikehara S, Nakanishi H, Ikehara Y.
    J Pathol; 2014 Oct 01; 234(2):228-38. PubMed ID: 25042889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.